MiR-106b-5p inhibits tumor necrosis factor-α-induced apoptosis by targeting phosphatase and tensin homolog deleted on chromosome 10 in vascular endothelial cells

Chinese Medical Journal

Volumn 129, Issue 12, 2016, Pages 1406-1412

  Zhang, Jing ^a   Li, Su Fang ^a   Chen, Hong ^a   Song, Jun Xian ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Atherosclerosis; MicroRNAs; Phosphatase and tensin homolog deleted on chromosome 10

Indexed keywords

CASPASE 3; MESSENGER RNA; MICRORNA; MICRORNA 106B 5P; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN106 MICRORNA, HUMAN; PROTEIN BINDING; PTEN PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ADULT; AGED; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; APOPTOSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROTEIN BINDING; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84971644010     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.183414     Document Type: Article

References (19)

1. Ross R. Atherosclerosis – An inflammatory disease. N Engl J Med 1999;340:115-26. doi: 10.1056/NEJM199901143400207.
2. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001;33:1673-90. doi: 10.1006/jmcc.2001.1419.
3. Dimmeler S, Hermann C, Zeiher AM. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw 1998;9:697-8.
4. Lafont A. Basic aspects of plaque vulnerability. Heart 2003;89:1262-7. doi: 10.1136/heart.89.10.1262.
5. Dimmeler S, Haendeler J, Zeiher AM. Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 2002;13:531-6. doi: 10.1097/00041433-200210000-00009.
6. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97. doi: 10.1016/S0092-8674(04)00045-5.
7. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-42. doi: 10.1038/nature09783.
8. Haver VG, Slart RH, Zeebregts CJ, Peppelenbosch MP, Tio RA. Rupture of vulnerable atherosclerotic plaques: MicroRNAs conducting the orchestra? Trends Cardiovasc Med 2010;20:65-71. doi: 10.1016/j.tcm.2010.04.002.
9. Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One 2013;8:e80738. doi: 10.1371/journal.pone.0080738.
10. Zhang J, Ren J, Chen H, Geng Q. Inflammation induced-endothelial cells release angiogenesis associated-microRNAs into circulation by microparticles. Chin Med J 2014;127:2212-7. doi: 10.3760/cma.j.issn.0366-6999.20133228.
11. Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1999;274:20693-703. doi: 10.1074/jbc.274.29.20693.
12. Yamada KM, Araki M.: Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001;114(Pt 13):2375-82.
13. Koide M, Ikeda K, Akakabe Y, Kitamura Y, Ueyama T, Matoba S, et al. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells. Proc Natl Acad Sci U S A 2011;108:9472-7. doi: 10.1073/pnas.1101296108.
14. Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002;277:10760-6. doi: 10.1074/jbc.M110219200.
15. Yu J, Eto M, Akishita M, Okabe T, Ouchi Y. A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells. Vascul Pharmacol 2009;51:21-8. doi: 10.1016/j.vph.2009.01.003.
16. Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:402-9. doi: 10.1161/01.ATV.20.2.402.
17. Kozomara A, Griffiths-Jones S.: miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152-7. doi: 10.1093/nar/gkq1027.
18. Trostdorf F, Landgraf C, Kablau M, Schmitz-Rixen T, Sitzer M. Increased endothelial cell apoptosis in symptomatic high-grade carotid artery stenosis: Preliminary data. Eur J Vasc Endovasc Surg 2007;33:65-8. doi: 10.1016/j.ejvs.2006.09.004.
19. Bulger DA, Conley J, Conner SH, Majumdar G, Solomon SS. Role of PTEN in TNFα induced insulin resistance. Biochem Biophys Res Commun 2015;461:533-6. doi: 10.1016/j.bbrc.2015.04.063.